TytoCare Revenue and Competitors
Estimated Revenue & Valuation
- TytoCare's estimated annual revenue is currently $83.8M per year.
- TytoCare received $9.0M in venture funding in January 2019.
- TytoCare's estimated revenue per employee is $313,750
- TytoCare's total funding is $156.7M.
Employee Data
- TytoCare has 267 Employees.
- TytoCare grew their employee count by 4% last year.
TytoCare's People
Name | Title | Email/Phone |
---|---|---|
1 | Area VP | Reveal Email/Phone |
2 | COO & Co-Founder | Reveal Email/Phone |
3 | CEO, Co-Founder | Reveal Email/Phone |
4 | VP, Customer Strategy & Growth | Reveal Email/Phone |
5 | VP Global Customer Success | Reveal Email/Phone |
6 | VP R&D | Reveal Email/Phone |
7 | VP Hardware & Innovation | Reveal Email/Phone |
8 | VP Operations | Reveal Email/Phone |
9 | VP Product | Reveal Email/Phone |
10 | VP People | Reveal Email/Phone |
TytoCare Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $274M | 1398 | N/A | N/A | N/A |
#2 | $159.3M | 472 | -4% | N/A | N/A |
#3 | $1.3M | 15 | -6% | N/A | N/A |
What Is TytoCare?
TytoCare is transforming primary care by putting health in the hands of consumers. We seamlessly connect people to clinicians to provide the best home examination and diagnosis solutions. TytoCare's mission is to delight consumers and clinicians alike by delivering easy, affordable and high quality telehealth visits, complete with medical exams, all from the comfort of home. TytoCare is introducing two telehealth products. TytoHome is a remote examination tool and telehealth platform that connects consumers to clinicians to enable a comprehensive medical examination (ears, nose, throat, lungs, heart and temperature) anytime and anywhere. TytoPro is a professional examination tool and telehealth platform that connects medical practitioners to each other to share remote exam data, conduct a specialist consultation, or get a second opinion. TytoPro can also be used in-office to share images with patients to explain diagnoses and motivate treatments. TytoCare was founded by Dedi Gilad, Ofer Tzadik and industry experts in 2012 with a vision to put health in the hands of the consumer. The Company has received over $18 million in funding from investors including Walgreens, Cambia Health Solutions, OrbiMed, Fosun Pharma, LionBird, and Teuza. For more information visit www.tytocare.com.
keywords:N/A$156.7M
Total Funding
267
Number of Employees
$83.8M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TytoCare News
Through TytoCare's FDA-cleared handheld examination kit, users can perform comprehensive physical exams of the heart, skin, ears, throat,...
TytoCare is a telehealth company using AI to transform primary care by putting health in the hands of consumers. TytoCare seamlessly connects...
TytoCare brings this vision one step further by enabling remote physical exams of the heart, skin, ears, throat, abdomen, and lungs, and...
What You Should Know: – Today at HLTH21, TytoCare launched an expansion of its video capabilities, including enhanced video quality, multi-party calls, and the ability for clinicians to conduct remote visits on any tablet, including iPads. – The enhanced video capabilities include top-of-the-l ...
NEW YORK, Aug. 17, 2021 /PRNewswire/ -- TytoCare, the global health care industry's first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams today announced its partnership with Prisma Health, the largest healthcare system in South Carolina. The in ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $58.6M | 267 | -14% | $78M |
#2 | $59.3M | 267 | 14% | N/A |
#3 | $42.6M | 267 | N/A | N/A |
#4 | $73.4M | 267 | -3% | N/A |
#5 | $41.1M | 267 | -12% | N/A |
TytoCare Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2018-01-30 | $25.0M | Undisclosed | Ping An Global Voyager Fund | Article |
2019-01-17 | $9.0M | Undisclosed | Sanford Health | Article |